Epidemiology of chronic kidney disease in heart failure -- Anemia and cardiovascular risk in the kidney disease patient -- Renal hemodynamic changes in heart failure -- Changes in kidney function following heart failure treatment: Focus on RAS Blockade -- Extracellular fluid volume in the hypoalbuminemic diabetic patient -- B-Type natriuretic peptide: Beyond a diagnostic criteria -- Hyperkalemia risk and treatment of heart failure -- Management of heart failure with renal artery ischemia -- Treatment of hypertension in heart failure with renal artery ischemia: Role of the kidney -- Renal consequences of prostaglandin inhibition in heart failure -- Edema mechanisms in the heart failure patient and treatment options -- Ultrafiltration for volume control in decompensated heart failure / Combination therapies -- Cost benefits of minimizing pill counts and dosing regimens -- New markers of vascular risk -- Dietary paradoxes to optimize cardiovascular risk management in CKD.

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.   The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.   This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.